Reach Us +44-1202068036
How To Deconstruct Cancer One Patient At The Time: The Wider Application Of The Paradigm Of Haematological Malignacies | 19848
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

How to deconstruct cancer one patient at the time: The wider application of the paradigm of haematological malignacies

2nd International Conference on Hematology & Blood Disorders

Effie Liakopoulou

Keynote: J Blood Disorders Transf

DOI: 10.4172/2155-9864.S1.005

Based on over 40 years of scientific, technological discovery and experience that there are better ways to treat cancer, a paradigm shift in diagnostics and clinical research is needed to ensure that new molecular insights are rapidly applied to shape emerging cancer therapies. Haematological malignancies have been a prime example of early phase of such approach leading to consequent benefit of other fields in oncology. Smarter and smaller clinical trials are necessary to capitalize on credible therapeutic signals and apply these to the treatment of early cancers for which major improvements in long term survival may be expected.
Effie Liakopoulou is a physician scientist, specialist in Hematology Stem Cell Transplantation with particular interests in Hematological Oncology, Cell Therapies and Personalized Medicine. She holds MD and PhD degrees and a Certificate in Medical Management. She has 21 years of international experience and sound knowledge of the landscape in science, research and technology on clinical, medical and regulatory matters. Since 2006 she has served as inspector for the Joint Accreditation Committee - International Society for Cellular Therapy & European Group for Blood and Marrow Transplantation performing audits and due diligence of clinical, laboratory, research and specialist stem cell facilities. She is a member of several international professional organizations, and in 2009 she was elected Fellow of the Royal College of Pathologists, UK, in recognition of her contributions to the field of Hematology. She has co-authored several peer-reviewed publications and articles. Currently, she is an Affiliate Faculty Member in Hematology at, UW Medicine and Senior Research role for Retroscreen LTD. She is leading the coordination of due diligence in the academic, biotechnology and pharmaceutical arenas for technologies and fostering alliances for the advancement of Cancer therapies, Medicine and Health care as a whole.
Relevant Topics